Lisa M Bebell1,2, Arnold Ayebare3,4, Yap Boum3,4, Mark J Siedner1,2, Joel Bazira4, Steven J Schiff5, Joshua P Metlay6, David R Bangsberg1,2, Stephen Ttendo4, Paul G Firth7. 1. Infectious Diseases Division, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. 2. Massachusetts General Hospital Center for Global Health, 125 Nashua Street, Boston, MA 02114, USA. 3. Epicentre Research Base, PO Box 1956, Mbarara, Uganda. 4. Mbarara University of Science and Technology, Mbarara, Uganda. 5. Center for Neural Engineering and Center for Infectious Disease Dynamics, Departments of Engineering Science and Mechanics, Neurosurgery and Physics, The Pennsylvania State University, University Park, PA, USA. 6. Division of General Internal Medicine, Massachusetts General Hospital, 50 Staniford Street, Boston, MA 02114, USA. 7. Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
Abstract
Background: Despite increasing antimicrobial resistance globally, data are lacking on prevalence and factors associated with Staphylococcus aureus (SA) and MRSA carriage in resource-limited settings. Objectives: To determine the prevalence of SA and MRSA nasal carriage and factors associated with carriage among Ugandan regional referral hospital patients. Methods: We enrolled a cross-section of 500 adults, sampling anterior nares for SA and MRSA carriage using Cepheid Xpert SA Nasal Complete. Results: Mean age was 37 years; 321 (64%) were female and 166 (33%) were HIV infected. Overall, 316 (63%) reported risk factors for invasive SA infection; 368 (74%) reported current antibiotic use. SA was detected in 29% and MRSA in 2.8%. MRSA and MSSA carriers were less likely than SA non-carriers to be female (50% and 56% versus 68%, P = 0.03) or to have recently used β-lactam antibiotics (43% and 65% versus 73%, P = 0.01). MRSA carriers were more likely to have open wounds than MSSA carriers and SA non-carriers (71% versus 27% and 40%, P = 0.001) and contact with pigs (21% versus 2% and 6%, P = 0.008). MRSA carriage ranged from 0% of HIV clinic participants to 8% of inpatient surgical ward participants ( P = 0.01). In multivariable logistic regression analysis, male sex was independently associated with SA carriage (OR 1.68, 95% CI 1.12-2.53, P = 0.01) and recent β-lactam antibiotic use was associated with reduced odds of SA carriage (OR 0.61, 95% CI 0.38-0.97, P = 0.04). Conclusions: MRSA nasal carriage prevalence was low and associated with pig contact, open wounds and surgical ward admission, but not with HIV infection.
Background: Despite increasing antimicrobial resistance globally, data are lacking on prevalence and factors associated with Staphylococcus aureus (SA) and MRSA carriage in resource-limited settings. Objectives: To determine the prevalence of SA and MRSA nasal carriage and factors associated with carriage among Ugandan regional referral hospital patients. Methods: We enrolled a cross-section of 500 adults, sampling anterior nares for SA and MRSA carriage using Cepheid Xpert SA Nasal Complete. Results: Mean age was 37 years; 321 (64%) were female and 166 (33%) were HIV infected. Overall, 316 (63%) reported risk factors for invasive SA infection; 368 (74%) reported current antibiotic use. SA was detected in 29% and MRSA in 2.8%. MRSA and MSSA carriers were less likely than SA non-carriers to be female (50% and 56% versus 68%, P = 0.03) or to have recently used β-lactam antibiotics (43% and 65% versus 73%, P = 0.01). MRSA carriers were more likely to have open wounds than MSSA carriers and SA non-carriers (71% versus 27% and 40%, P = 0.001) and contact with pigs (21% versus 2% and 6%, P = 0.008). MRSA carriage ranged from 0% of HIV clinic participants to 8% of inpatient surgical ward participants ( P = 0.01). In multivariable logistic regression analysis, male sex was independently associated with SA carriage (OR 1.68, 95% CI 1.12-2.53, P = 0.01) and recent β-lactam antibiotic use was associated with reduced odds of SA carriage (OR 0.61, 95% CI 0.38-0.97, P = 0.04). Conclusions: MRSA nasal carriage prevalence was low and associated with pig contact, open wounds and surgical ward admission, but not with HIV infection.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: James A McKinnell; Loren G Miller; Samantha J Eells; Eric Cui; Susan S Huang Journal: Infect Control Hosp Epidemiol Date: 2013-08-19 Impact factor: 3.254
Authors: Heiman F L Wertheim; Damian C Melles; Margreet C Vos; Willem van Leeuwen; Alex van Belkum; Henri A Verbrugh; Jan L Nouwen Journal: Lancet Infect Dis Date: 2005-12 Impact factor: 25.071
Authors: R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin Journal: JAMA Date: 2007-10-17 Impact factor: 56.272
Authors: Jaishri Mehraj; Manas K Akmatov; Julia Strömpl; Anja Gatzemeier; Franziska Layer; Guido Werner; Dietmar H Pieper; Eva Medina; Wolfgang Witte; Frank Pessler; Gérard Krause Journal: PLoS One Date: 2014-09-24 Impact factor: 3.240
Authors: Tara C Smith; Wondwossen A Gebreyes; Melanie J Abley; Abby L Harper; Brett M Forshey; Michael J Male; H Wayne Martin; Bayleyegn Z Molla; Srinand Sreevatsan; Siddhartha Thakur; Madhumathi Thiruvengadam; Peter R Davies Journal: PLoS One Date: 2013-05-07 Impact factor: 3.240
Authors: A Ayebare; L M Bebell; J Bazira; S Ttendo; V Katawera; D R Bangsberg; M J Siedner; P G Firth; Y Boum Ii Journal: BMC Microbiol Date: 2019-08-22 Impact factor: 4.465
Authors: David Patrick Kateete; Benon B Asiimwe; Raymond Mayanja; Brian Mujuni; Freddie Bwanga; Christine F Najjuka; Karin Källander; Elizeus Rutebemberwa Journal: BMC Infect Dis Date: 2019-12-02 Impact factor: 3.090